Epizyme Inc
Biotechnology
Healthcare
EPZM
144 M shares
NASDAQ US
traded
11 Aug 2022
listed
yes
open
1.49
52 week high
9.71
high
1.50
52 week low
1.36
low
1.47
growth
-69.75 %
previous Close
1.49
P/E ratio
market cap
247 M
div yield
0
usd
Jun 2022
qoq
revenue
27.53 M
216.56 %
net incoming
-35.74 M
35.60 %
eps
0.00 %
44.74 %
eps surprise
41.67 %
net profit margin
-129.85 %
508.00 %
operating incoming
-34.98 M
0.00 %
net change in cash
-6.36 M
69.62 %
cash on hand
71.07 M
-8.21 %
cost of revenue
5.17 M
0.00 %
top top